Literature DB >> 22649196

Purinergic P2X7 receptor drives T cell lineage choice and shapes peripheral γδ cells.

Michela Frascoli1, Jessica Marcandalli, Ursula Schenk, Fabio Grassi.   

Abstract

TCR signal strength instructs αβ versus γδ lineage decision in immature T cells. Increased signal strength of γδTCR with respect to pre-TCR results in induction of the γδ differentiation program. Extracellular ATP evokes physiological responses through purinergic P2 receptors expressed in the plasma membrane of virtually all cell types. In peripheral T cells, ATP released upon TCR stimulation enhances MAPK activation through P2X receptors. We investigated whether extracellular ATP and P2X receptors signaling tuned TCR signaling at the αβ/γδ lineage bifurcation checkpoint. We show that P2X7 expression was selectively increased in immature γδ(+)CD25(+) cells. These cells were much more competent to release ATP than pre-TCR-expressing cells following TCR stimulation and Ca(2+) influx. Genetic ablation as well as pharmacological antagonism of P2X7 resulted in impaired ERK phosphorylation, reduction of early growth response (Egr) transcripts induction, and diversion of γδTCR-expressing thymocytes toward the αβ lineage fate. The impairment of the ERK-Egr-inhibitor of differentiation 3 (Id3) signaling pathway in γδ cells from p2rx7(-/-) mice resulted in increased representation of the Id3-independent NK1.1-expressing γδ T cell subset in the periphery. Our results indicate that ATP release and P2X7 signaling upon γδTCR expression in immature thymocytes constitutes an important costimulus in T cell lineage choice through the ERK-Egr-Id3 signaling pathway and contributes to shaping the peripheral γδ T cell compartment.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22649196     DOI: 10.4049/jimmunol.1101582

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  18 in total

Review 1.  Purinergic Signaling and the Immune Response in Sepsis: A Review.

Authors:  Carola Ledderose; Yi Bao; Yutaka Kondo; Mahtab Fakhari; Christian Slubowski; Jingping Zhang; Wolfgang G Junger
Journal:  Clin Ther       Date:  2016-05-05       Impact factor: 3.393

2.  Noncanonical mode of ERK action controls alternative αβ and γδ T cell lineage fates.

Authors:  Sang-Yun Lee; Francis Coffey; Shawn P Fahl; Suraj Peri; Michele Rhodes; Kathy Q Cai; Michael Carleton; Stephen M Hedrick; Hans Joerg Fehling; Juan Carlos Zúñiga-Pflücker; Dietmar J Kappes; David L Wiest
Journal:  Immunity       Date:  2014-11-28       Impact factor: 31.745

3.  P2X7 receptor activation induces reactive oxygen species formation in erythroid cells.

Authors:  Bin Wang; Ronald Sluyter
Journal:  Purinergic Signal       Date:  2012-09-27       Impact factor: 3.765

4.  Dynamic regulation of CD24 expression and release of CD24-containing microvesicles in immature B cells in response to CD24 engagement.

Authors:  D Craig Ayre; Marcus Elstner; Nicole C Smith; Emily S Moores; Andrew M Hogan; Sherri L Christian
Journal:  Immunology       Date:  2015-07-15       Impact factor: 7.397

Review 5.  The ectonucleotidases CD39 and CD73: Novel checkpoint inhibitor targets.

Authors:  Bertrand Allard; Maria Serena Longhi; Simon C Robson; John Stagg
Journal:  Immunol Rev       Date:  2017-03       Impact factor: 12.988

6.  The P2X7 receptor is a target of p53 and regulates haematopoiesis following radiation-induced genotoxic stress.

Authors:  Peter Cuthbertson; Ronald Sluyter
Journal:  Purinergic Signal       Date:  2022-01-04       Impact factor: 3.765

Review 7.  Corneal pain and experimental model development.

Authors:  Tina B McKay; Yashar Seyed-Razavi; Chiara E Ghezzi; Gabriela Dieckmann; Thomas J F Nieland; Dana M Cairns; Rachel E Pollard; Pedram Hamrah; David L Kaplan
Journal:  Prog Retin Eye Res       Date:  2018-11-16       Impact factor: 21.198

8.  P2X7 Receptor Activity Limits Accumulation of T Cells within Tumors.

Authors:  Andrea Romagnani; Elsa Rottoli; Emilia Maria Cristina Mazza; Tanja Rezzonico-Jost; Benedetta De Ponte Conti; Michele Proietti; Michela Perotti; Elisa Civanelli; Lisa Perruzza; Alberico L Catapano; Andrea Baragetti; Elena Tenedini; Enrico Tagliafico; Simonetta Falzoni; Francesco Di Virgilio; Giuseppe Danilo Norata; Silvio Bicciato; Fabio Grassi
Journal:  Cancer Res       Date:  2020-07-22       Impact factor: 12.701

Review 9.  Extracellular vesicles in cancer immune responses: roles of purinergic receptors.

Authors:  Michael W Graner
Journal:  Semin Immunopathol       Date:  2018-09-12       Impact factor: 9.623

Review 10.  Purinergic Receptors: Key Mediators of HIV-1 Infection and Inflammation.

Authors:  Talia H Swartz; George R Dubyak; Benjamin K Chen
Journal:  Front Immunol       Date:  2015-11-26       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.